ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 216 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,978,332 | +3.8% | 150,558 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $1,905,926 | -11.4% | 151,264 | -8.2% | 0.00% | 0.0% |
| Q1 2023 | $2,150,693 | -24.9% | 164,804 | +1.6% | 0.00% | -33.3% |
| Q4 2022 | $2,862,408 | +13.6% | 162,268 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $2,519,000 | +3.7% | 165,449 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $2,428,000 | -38.5% | 163,725 | -6.6% | 0.00% | 0.0% |
| Q1 2022 | $3,949,000 | +24.3% | 175,349 | +1.8% | 0.00% | +50.0% |
| Q4 2021 | $3,178,000 | +87.6% | 172,209 | +35.9% | 0.00% | +100.0% |
| Q3 2021 | $1,694,000 | -40.7% | 126,701 | -17.9% | 0.00% | -50.0% |
| Q2 2021 | $2,856,000 | +20.9% | 154,317 | -1.9% | 0.00% | +100.0% |
| Q1 2021 | $2,362,000 | -6.3% | 157,262 | -10.0% | 0.00% | 0.0% |
| Q4 2020 | $2,522,000 | +139.3% | 174,647 | +34.9% | 0.00% | 0.0% |
| Q3 2020 | $1,054,000 | +30.9% | 129,462 | +8.8% | 0.00% | 0.0% |
| Q2 2020 | $805,000 | +1.1% | 118,956 | +5.2% | 0.00% | 0.0% |
| Q1 2020 | $796,000 | -53.0% | 113,096 | -34.4% | 0.00% | 0.0% |
| Q4 2019 | $1,692,000 | +8.0% | 172,511 | +20.9% | 0.00% | 0.0% |
| Q3 2019 | $1,567,000 | -86.8% | 142,698 | -86.1% | 0.00% | -90.9% |
| Q2 2019 | $11,901,000 | +590.3% | 1,023,276 | +466.5% | 0.01% | +450.0% |
| Q1 2019 | $1,724,000 | +8.1% | 180,622 | +9.2% | 0.00% | 0.0% |
| Q4 2018 | $1,595,000 | -31.0% | 165,434 | +2.1% | 0.00% | 0.0% |
| Q3 2018 | $2,310,000 | -60.6% | 162,026 | -66.8% | 0.00% | -66.7% |
| Q2 2018 | $5,859,000 | -2.5% | 488,246 | +0.3% | 0.01% | 0.0% |
| Q1 2018 | $6,011,000 | +85.5% | 486,804 | +118.6% | 0.01% | +100.0% |
| Q4 2017 | $3,241,000 | -15.3% | 222,740 | -17.2% | 0.00% | -25.0% |
| Q3 2017 | $3,827,000 | +100.8% | 268,947 | +79.9% | 0.00% | +100.0% |
| Q2 2017 | $1,906,000 | +2.2% | 149,474 | +1.6% | 0.00% | 0.0% |
| Q1 2017 | $1,865,000 | -31.4% | 147,132 | -44.8% | 0.00% | -33.3% |
| Q4 2016 | $2,720,000 | -1.2% | 266,429 | +27.6% | 0.00% | 0.0% |
| Q3 2016 | $2,752,000 | -14.9% | 208,877 | -17.9% | 0.00% | -25.0% |
| Q2 2016 | $3,233,000 | -36.1% | 254,564 | -33.5% | 0.00% | -33.3% |
| Q1 2016 | $5,058,000 | -0.5% | 382,859 | +15.9% | 0.01% | 0.0% |
| Q4 2015 | $5,081,000 | +29.6% | 330,392 | +4.5% | 0.01% | +20.0% |
| Q3 2015 | $3,922,000 | -13.2% | 316,272 | -4.2% | 0.01% | +25.0% |
| Q2 2015 | $4,517,000 | +35.0% | 330,254 | +18.1% | 0.00% | +33.3% |
| Q1 2015 | $3,345,000 | -16.2% | 279,660 | -10.5% | 0.00% | -25.0% |
| Q4 2014 | $3,990,000 | -31.9% | 312,393 | -28.5% | 0.00% | -20.0% |
| Q3 2014 | $5,858,000 | +12.0% | 436,620 | +34.0% | 0.01% | +25.0% |
| Q2 2014 | $5,230,000 | -11.9% | 325,912 | -1.0% | 0.00% | -33.3% |
| Q1 2014 | $5,934,000 | -1.2% | 329,150 | -15.3% | 0.01% | +20.0% |
| Q4 2013 | $6,009,000 | +16.7% | 388,751 | +12.3% | 0.01% | 0.0% |
| Q3 2013 | $5,149,000 | +23.3% | 346,231 | +7.3% | 0.01% | +25.0% |
| Q2 2013 | $4,177,000 | +70.7% | 322,824 | +79.3% | 0.00% | +100.0% |
| Q1 2013 | $2,447,000 | – | 180,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |